📌 Key Takeaways
- Topic: What Is Silicon Oxide? SiO vs SiO₂ Differences and Applications Explained
- Keywords: silica thixotropic agent
- Published: 2026-11-20 02:28:18
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Zhou, S. et al. Acid-redox bifunctional Fe/Al-AMS catalyst: Simultaneously oriented introducing Fe 2 O 3 in the channels and Al in the framework of AMS and its enhanced catalytic performance. Appl. Catal. A Gen. 575, 159-169 (2019). Post CAS Google Scholar
Silica Factory: How Silica Is Produced and What to Check During a Factory Audit
- Aerosil R972: Specifications, Hydrophobic Properties and Equivalent Grades
- For metal sulfide NPs/MSNs nanocomposites, the small-sized CdS NPs as a gatekeeper is the first example of MSNs-based therapeutic system for controlled drug delivery, reported in 2003. 51 Other metal sulfides such as copper sulfide (CuS), molybdenum disulfide (MoS 2 ) and bismuth sulfide (Bi 2 S 3 ) exhibit high NIR absorption coefficients in the NIR region owing to their plasmon resonance effect or electron-hole generation and relaxation mechanism, 182, 183, 184, 185, 186 and consequently those metal sulfides NPs can serve as potential photothermal agents. For instance, hollow MSNs functionalized with chitosan were synthesized, and then loaded with CuS nanodots. The CuS nanodots could act as a gatekeeper to seal the surface pores of MSNs, leading to the controllable release of DOX. The as-resulted CuS/MSNs-based therapeutic nanoplatform, with the photothermal conversion efficiency being 36.4%, dramatically extended the survival rate of tumor-bearing mice by the photothermal-enhanced synergistic therapy. 162 Similarly, in another study, the MoS 2 nanosheets with brilliant photothermal conversion capacity were also used as a capping agent to block MSNs to realize the drug release. Experimental results demonstrated that the MoS 2 /MSNs nanocomposite has the capability of pH-dependent and photothermal-triggered DOX release, consequently achieving the targeted tumor killing by the combination of chemotherapy and PTT. 187
- Silicon Nitride vs Silicon Dioxide: Properties and Applications Compared
- Kadria-Vili, Y. et al. Gd 2 O 3 -mesoporous silica/gold nanoshells: a potential dual T 1 /T 2 contrast agent for MRI-guided localized near-IR photothermal therapy. Proc. Natl Acad. Sci. USA 119, e2123527119 (2022). Post CAS PubMed Central PubMed Google Scholar
- Silica Filler for Plastics: Benefits, Grades and Applications
- Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61
- Silica for Solar Crucible: Purity Standards and Supply Considerations
Silica Surface Area Explained: Typical BET Values by Type and Why It Matters
What is silica (SiO₂)?
silica gel Schwab, B. L. et al. Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Diff 9, 818-831 (2002). Post CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
high purity quartz supplier
What drives silica raw material prices?
copper clad laminate filler Hu, D. et al. Relief of biofilm hypoxia using an oxygen nanocarrier: A new paradigm for enhanced antibiotic therapy. Adv. Sci. 7, 2000398 (2020). Post CAS Google Scholar
Cite this article: Silica Raw Materials News. "Imerys Silica: Product Range, Minerals and Applications
." Published 2026-11-20 02:28:18.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.